NasdaqGS - Delayed Quote USD

Humacyte, Inc. (HUMA)

1.8900
+0.0200
+(1.07%)
At close: May 15 at 4:00:00 PM EDT
1.8900
0.00
(0.00%)
Pre-Market: 8:43:20 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
114,398
114,398
96,940
84,578
81,208
Operating Income
-114,398
-114,398
-96,940
-84,578
-81,208
Net Non Operating Interest Income Expense
-5,173
-5,173
-1,132
-3,571
-4,332
Other Income Expense
-29,130
-29,130
-12,704
76,184
59,063
Pretax Income
-148,701
-148,701
-110,776
-11,965
-26,477
Net Income Common Stockholders
-148,701
-148,701
-110,776
-11,965
-26,477
Diluted NI Available to Com Stockholders
-148,701
-148,701
-110,776
-11,965
-26,477
Basic EPS
-1.26
--
-1.07
-0.12
-0.66
Diluted EPS
-1.26
--
-1.07
-0.12
-0.66
Basic Average Shares
118,479.0970
--
103,420.2380
103,051.3660
39,970.3980
Diluted Average Shares
118,479.0970
--
103,420.2380
103,051.3660
39,970.3980
Total Operating Income as Reported
-114,398
-114,398
-100,047
-84,578
-81,208
Total Expenses
114,398
114,398
96,940
84,578
81,208
Net Income from Continuing & Discontinued Operation
-148,701
-148,701
-110,776
-11,965
-26,477
Normalized Income
-119,571
-119,571
-98,072
-88,149
-85,540
Interest Income
4,104
4,104
5,467
2,629
16
Interest Expense
9,277
9,277
6,599
6,200
4,348
Net Interest Income
-5,173
-5,173
-1,132
-3,571
-4,332
EBIT
-139,424
-139,424
-104,177
-5,765
-22,129
EBITDA
-132,234
-132,234
-96,458
2,445
-13,888
Reconciled Depreciation
7,190
7,190
7,719
8,210
8,241
Net Income from Continuing Operation Net Minority Interest
-148,701
-148,701
-110,776
-11,965
-26,477
Total Unusual Items Excluding Goodwill
-29,130
-29,130
-12,704
76,184
59,063
Total Unusual Items
-29,130
-29,130
-12,704
76,184
59,063
Normalized EBITDA
-103,104
-103,104
-83,754
-73,739
-72,951
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 12/1/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XLO Xilio Therapeutics, Inc.
0.8000
-5.88%
 
CNSP CNS Pharmaceuticals, Inc.
1.2600
+9.57%
 
CTMX CytomX Therapeutics, Inc.
2.0000
-15.97%
 
IOVA Iovance Biotherapeutics, Inc.
1.7600
+3.23%
 
HCWB HCW Biologics Inc.
8.20
-6.92%
 
NCNA NuCana plc
0.0534
+54.34%
 
ABSI Absci Corporation
2.9600
+1.72%
 
SGMO Sangamo Therapeutics, Inc.
0.4500
+2.74%
 
QNRX Quoin Pharmaceuticals, Ltd.
7.70
+0.65%
 
ABP Abpro Holdings, Inc.
0.2651
+60.67%